Evidence map›Paper›PMID 30910902›Full record

ArticleAntimicrobial agents and chemotherapy2019

Indirubin Analogues Inhibit

Antonia Efstathiou, Nicolas Gaboriaud-Kolar, Vassilios Myrianthopoulos, Konstantina Vougogiannopoulou, Ines Subota, Stephanie Aicher, Emmanuel Mikros, Philippe Bastin, Alexios-Leandros Skaltsounis, Ketty Soteriadou and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Targeted protein degradation might present a novel therapeutic approach in the fight against African trypanosomiasis.European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2023
    Article
  2. Article
  3. Microorganisms · 2021
    Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Antonia EfstathiouDepartment of Microbiology, Hellenic Pasteur Institute, Athens, Greece.
Nicolas Gaboriaud-KolarDepartment of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece.
Vassilios MyrianthopoulosDepartment of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece.
Konstantina VougogiannopoulouDepartment of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece.
Ines SubotaTrypanosome Cell Biology Unit, INSERM U1201, Institut Pasteur, Paris, France.
Stephanie AicherDepartment of Microbiology, Hellenic Pasteur Institute, Athens, Greece.
Emmanuel MikrosDepartment of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece.
Philippe BastinTrypanosome Cell Biology Unit, INSERM U1201, Institut Pasteur, Paris, France.
Alexios-Leandros SkaltsounisDepartment of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece.
Ketty SoteriadouDepartment of Microbiology, Hellenic Pasteur Institute, Athens, Greece.
Despina SmirlisDepartment of Microbiology, Hellenic Pasteur Institute, Athens, Greece penny@pasteur.gr.
National and Kapodistrian University of Athens · GRPasteur Hellenic Institute · GRAthena Research and Innovation Center In Information Communication & Knowledge Technologies · GRInserm · FRInstitut Pasteur · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The protozoan parasite

Indexed as

AnimalsCell LineGlycogen Synthase Kinase 3IndolesInsectaProtein Kinase InhibitorsStructure-Activity RelationshipTrypanocidal AgentsTrypanosoma brucei bruceiTrypanosomiasis, AfricanGlycogen Synthase Kinase 3indirubinIndolesProtein Kinase InhibitorsTrypanocidal Agentsdrug discoveryGSK3indirubinskinase inhibitionTrypanosoma brucei

Identifiers

PMID30910902
PMCPMC6535550
OpenAlexW2925113498

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.